Webinar: Reimagining Data Management for Faster, Smarter Bioprocess Development

Dirty data is one of the biggest impediments to reducing the time to commercial readiness for new biopharmaceuticals. This is because the traditional approach to data capture in bioprocess development is complex. A siloed combination of ELN, LIMS and instrument integrations leads to blind spots throughout the BioPharma lifecycle.

Like cooking in a messy kitchen, it’s hard to discover and apply process findings in such a disjointed data landscape. Data scientists typically spend 80-90% of their time cleaning and reformatting data which leaves very little time for analysis.

IDBS’ Polar BioProcess is designed to simplify how data is captured and contextualized within a digital data backbone, to make process understanding easier and more efficient.

Polar BioProcess provides an end-to-end solution for process/data tracking from early development through manufacturing, providing the capacity to perform comprehensive analytics, simplify tech transfer, and reduce time to commercial milestones.

In this session, you will learn: 

  • Current challenges in bioprocess development digitalization
  • Best practices for laying the foundation for advanced analytics, AI/ML
  • Business benefits of a digital data backbone
View On-Demand

Speaker: 

Michael Barnes, Lead Solutions Consultant, IDBS

As part of the Solutions team, Michael Barnes helps companies develop and coordinate technical solutions to address their various challenges and needs. 

Michael was a multidisciplinary bench scientist and worked in various roles and companies, from isolating rare and underrepresented cancers at the Broad Institute to automating cell-based toxicology assays in a CRO setting. Prior to joining IDBS, Michael spent three years in Pfizer’s BioProcess R&D Cell Line Development group, working to evaluate different vectors/expression systems and investigate phenotypic challenges at a genotypic level. 

Michael holds a BS in Physiology and Kinesiology from the University of Florida and a master’s degree in Biomedical Engineering, Cellular and Molecular Biology from the University of Massachusetts, Lowell. 

View On-Demand Now!